Bone Biologics (BBLGW) Non-Current Assets (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Non-Current Assets for 2 consecutive years, with $170.0 as the latest value for Q3 2017.
- Quarterly Non-Current Assets fell 39.72% to $170.0 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $824.0 through Sep 2017, changed N/A year-over-year, with the annual reading at $242.0 for FY2016, N/A changed from the prior year.
- Non-Current Assets for Q3 2017 was $170.0 at Bone Biologics, down from $194.0 in the prior quarter.
- The five-year high for Non-Current Assets was $362.0 in Q1 2016, with the low at $170.0 in Q3 2017.